Search Results

Outcomes in Participants with Renal Impairment from a Phase 3 Clinical Trial for Ceftolozane/Tazobactam Treatment of Nosocomial Pneumonia (ASPECT-NP).

• Authors : Huntington JA; Merck & Co., Inc., Kenilworth, New Jersey, USA.; Yu B

Subjects: Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/therapeutic use ; Cephalosporins*/Cephalosporins*/Cephalosporins*/therapeutic use ; Cross Infection*/Cross Infection*/Cross Infection*/drug therapy

• Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2020 Nov 17; Vol. 64 (12). Date of Electronic Publication: 2020 Nov 17 (Print Publication: 2020).Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Electronic-Print Cited Medium:

Record details

Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015-2017) Pseudomonas aeruginosa isolates from a global surveillance programme.

• Authors : Shortridge D; JMI Laboratories, 345 Beaver Kreek Centre, Suite A, North Liberty, IA 52317, USA. Electronic address: .; Pfaller MA

Subjects: Cephalosporins/Cephalosporins/Cephalosporins/*pharmacology ; Pneumonia/Pneumonia/Pneumonia/*microbiology ; Pseudomonas Infections/Pseudomonas Infections/Pseudomonas Infections/*epidemiology

• Source: Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2020 Jun; Vol. 21, pp. 60-64. Date of Electronic Publication: 2019 Oct 21.Publisher: Published by Elsevier Ltd. on behalf of International Society of Chemotherapy for Infection and Cancer Country of Publication: Netherlands NLM ID:

Record details

Ceftolozane/Tazobactam treatment for patients with hospital-acquired and ventilatory-associated bacterial pneumonia in Canada in 2022–2024: results from the CLEAR registry.

• Authors : Zhanel, George G.; Dhami, Rita; Baxter, Melanie

• Source: Expert Review of Anti-infective Therapy; Dec2024, Vol. 22 Issue 12, p1221-1228, 8p

Record details

Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa.

• Authors : Lodise, Thomas P; Obi, Engels N; Watanabe, Alexandre H

Subjects: PATIENT readmissions; PROSTATE-specific antigen; TAZOBACTAM

• Source: Journal of Antimicrobial Chemotherapy (JAC); Nov2024, Vol. 79 Issue 11, p2954-2964, 11p

Record details

Agricola

Record details

Preventing Pneumonia in High-risk Patients After Esophageal Cancer Surgery: Mini-tracheostomy and Tazobactam/Piperacillin.

• Authors : MITSUO NISHIYAMA; SHIGERU TAKEDA; YUSAKU WATANABE

Subjects: PNEUMONIA prevention; TREATMENT of esophageal cancer; TAZOBACTAM

• Source: In Vivo; Jul/Aug2024, Vol. 38 Issue 4, p1790-1798, 9p

Record details

Efficacy and Safety Analysis of Piperacillin Tazobactam in Combination With High Frequency Chest Wall Oscillation in Patients With COPD Coupled With Pneumonia.

• Authors : Li Li; Qiong Feng; Qinghua Meng

Subjects: CHRONIC obstructive pulmonary disease; PNEUMONIA; PIPERACILLIN

• Source: Alternative Therapies in Health & Medicine. Jan/Feb2023, Vol. 29 Issue 1, p124-129. 6p.

Record details

Ceftolozane/Tazobactam for the Treatment of Complicated Infections in Hospital Settings—A French Real-world Study.

• Authors : Timsit, Jean-François; Mootien, Joy; Akrich, Brune

Subjects: URINARY tract infections; KLEBSIELLA pneumoniae; INTRA-abdominal infections

• Source: Open Forum Infectious Diseases; Feb2024, Vol. 11 Issue 2, p1-8, 8p

Record details

Investigators from Hospital Clinic San Carlos Target Pneumonia (Ceftolozane-tazobactam In Nosocomial Pneumonia)

• Source: Obesity, Fitness & Wellness Week. March 18, 2023, 2381

Record details

Pragmatic Comparison of Piperacillin/Tazobactam versus Carbapenems in Treating Patients with Nosocomial Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae.

• Authors : Zha, Lei; Li, Xiang; Ren, Zhichu

Subjects: KLEBSIELLA infections; KLEBSIELLA pneumoniae; CARBAPENEMS

• Source: Antibiotics (2079-6382); Oct2022, Vol. 11 Issue 10, pN.PAG-N.PAG, 14p

Record details